Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DDI of Ciprofol with Mefanamic Acid or Valproate
NCT05181007Phase 1Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- Dec 2021
- Primary completion
- Mar 2022
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label trial of ciprofol in Anesthesia and sedation (2 arms), sponsored by Haisco Pharmaceutical Group Co., Ltd. Primary endpoints: Maximum Plasma Concentration (Cmax) of Ciprofol and Area Under the Plasma Concentration-Time Curve (AUC) of Ciprofol. Started Dec 2021; status: completed.
02
Drugs
ciprofol
03
Conditions
Anesthesiasedation
Beyond the preview
Go deeper on NCT05181007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05181007.